AR Asset Management »

Marker Therapeutics Ord shares owned by AR Asset Management

Quarter-by-quarter ownership of Marker Therapeutics Ord shares owned by AR Asset Management from 13F filings

Historical chart of AR Asset Management investment in Marker Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Marker Therapeutics Ord held by AR Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Marker Therapeutics Ord by AR Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $389k 71k 5.50
2023-09-30 $321k 71k 4.54
2023-06-30 $126k 41k 3.10
2023-03-31 $29k 41k 0.71
2022-09-30 $103k 279k 0.37
2022-06-30 $92k 279k 0.33
2022-03-31 $123k 279k 0.44
2021-12-31 $68k 72k 0.95
2021-09-30 $472k 279k 1.69
2021-06-30 $781k 280k 2.79

More positions owned by AR Asset Management

Apple (AAPL)
Chevron Corporation (CVX)
Merck & Co (MRK)
JPMorgan Chase & Co. (JPM)
Procter & Gamble Company (PG)
Philip Morris International (PM)
Coca-Cola Company (KO)
Berkshire Hathaway (BRK.A)
Alphabet Inc Class C cs (GOOG)
Iron Mountain (IRM)
Microsoft Corporation (MSFT)
Nike (NKE)
Target Corporation (TGT)
Berkshire Hathaway (BRK.B)
Pepsi (PEP)

View all positions for AR Asset Management

Top funds holding Marker Therapeutics Ord

AR Asset Management

View all funds holding Marker Therapeutics Ord